Dyne Therapeutics
IPOA biotechnology company developing nucleic acid therapies for rare diseases.
Public · Waltham, United States · Founded 2017 · $165.0M raised
- Headquarters
- Waltham, Massachusetts
- Employees
- 201–500
- Founded
- 2017
- Business Model
- B2B
- Website
- dyne-tx.com
- Total Funding
- $165.0M
- Last Round
- $115.0M Series BAug 2020
- Rounds
- 2
- Type
- Public
About
Dyne Therapeutics is a clinical-stage biopharma developing targeted nucleic acid therapies for neuromuscular diseases. FORCE platform targets DMD, DM1, FSHD.
Summary
Dyne Therapeutics is a Biotech company based in Waltham, United States, founded in 2017. It has raised $165.0M in total across 2 rounds, most recently a $115.0M Series B round in Aug 2020. Investors include Atlas Venture, Forbion Capital Partners and MPM Capital.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2020
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...